-
1
-
-
0036636871
-
Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941
-
10.1016/S0022-5347(05)64820-3, 12050481
-
Huggins C, Hodges CV. Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941. J Urol 2002, 168:9-12. 10.1016/S0022-5347(05)64820-3, 12050481.
-
(2002)
J Urol
, vol.168
, pp. 9-12
-
-
Huggins, C.1
Hodges, C.V.2
-
2
-
-
79952253824
-
EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer
-
10.1016/j.eururo.2011.01.025, 21315502
-
Mottet N, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, Schmid HP, Van der Kwast T, Wiegel T, Zattoni F, Heidenreich A. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol 2011, 59:572-583. 10.1016/j.eururo.2011.01.025, 21315502.
-
(2011)
Eur Urol
, vol.59
, pp. 572-583
-
-
Mottet, N.1
Bellmunt, J.2
Bolla, M.3
Joniau, S.4
Mason, M.5
Matveev, V.6
Schmid, H.P.7
Van der Kwast, T.8
Wiegel, T.9
Zattoni, F.10
Heidenreich, A.11
-
3
-
-
0035152026
-
Nonsteroidal antiandrogens: a therapeutic option for patients with advanced prostate cancer who wish to retain sexual interest and function
-
10.1046/j.1464-410x.2001.00988.x, 11121992
-
Iversen P, Melezinek I, Schmidt A. Nonsteroidal antiandrogens: a therapeutic option for patients with advanced prostate cancer who wish to retain sexual interest and function. BJU Int 2001, 87:47-56. 10.1046/j.1464-410x.2001.00988.x, 11121992.
-
(2001)
BJU Int
, vol.87
, pp. 47-56
-
-
Iversen, P.1
Melezinek, I.2
Schmidt, A.3
-
4
-
-
0036448932
-
Bicalutamide: in early-stage prostate cancer
-
discussion 2480-2471, 10.2165/00003495-200262170-00006, 12421104
-
Carswell CI, Figgitt DP. Bicalutamide: in early-stage prostate cancer. Drugs 2002, 62:2471-2479. discussion 2480-2471, 10.2165/00003495-200262170-00006, 12421104.
-
(2002)
Drugs
, vol.62
, pp. 2471-2479
-
-
Carswell, C.I.1
Figgitt, D.P.2
-
5
-
-
0033789619
-
Gynecomastia in patients with prostate cancer: a review of treatment options
-
10.1016/S0090-4295(00)00823-2, 11068286
-
McLeod DG, Iversen P. Gynecomastia in patients with prostate cancer: a review of treatment options. Urology 2000, 56:713-720. 10.1016/S0090-4295(00)00823-2, 11068286.
-
(2000)
Urology
, vol.56
, pp. 713-720
-
-
McLeod, D.G.1
Iversen, P.2
-
6
-
-
5444248630
-
Bicalutamide 150 mg in addition to standard care in patients with localized or locally advanced prostate cancer: results from the second analysis of the early prostate cancer program at median followup of 5.4 years
-
10.1097/01.ju.0000140159.94703.80, 15540740
-
Wirth MP, See WA, McLeod DG, Iversen P, Morris T, Carroll K. Bicalutamide 150 mg in addition to standard care in patients with localized or locally advanced prostate cancer: results from the second analysis of the early prostate cancer program at median followup of 5.4 years. J Urol 2004, 172:1865-1870. 10.1097/01.ju.0000140159.94703.80, 15540740.
-
(2004)
J Urol
, vol.172
, pp. 1865-1870
-
-
Wirth, M.P.1
See, W.A.2
McLeod, D.G.3
Iversen, P.4
Morris, T.5
Carroll, K.6
-
7
-
-
33644857333
-
Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer
-
10.1111/j.1464-410X.2005.06051.x, 16430622
-
McLeod DG, Iversen P, See WA, Morris T, Armstrong J, Wirth MP. Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer. BJU Int 2006, 97:247-254. 10.1111/j.1464-410X.2005.06051.x, 16430622.
-
(2006)
BJU Int
, vol.97
, pp. 247-254
-
-
McLeod, D.G.1
Iversen, P.2
See, W.A.3
Morris, T.4
Armstrong, J.5
Wirth, M.P.6
-
8
-
-
20044376091
-
Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer
-
10.1200/JCO.2005.12.013, 15681525
-
Boccardo F, Rubagotti A, Battaglia M, Di Tonno P, Selvaggi FP, Conti G, Comeri G, Bertaccini A, Martorana G, Galassi P, Zattoni F, Macchiarella A, Siragusa A, Muscas G, Durand F, Potenzoni D, Manganelli A, Ferraris V, Montefiore F. Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer. J Clin Oncol 2005, 23:808-815. 10.1200/JCO.2005.12.013, 15681525.
-
(2005)
J Clin Oncol
, vol.23
, pp. 808-815
-
-
Boccardo, F.1
Rubagotti, A.2
Battaglia, M.3
Di Tonno, P.4
Selvaggi, F.P.5
Conti, G.6
Comeri, G.7
Bertaccini, A.8
Martorana, G.9
Galassi, P.10
Zattoni, F.11
Macchiarella, A.12
Siragusa, A.13
Muscas, G.14
Durand, F.15
Potenzoni, D.16
Manganelli, A.17
Ferraris, V.18
Montefiore, F.19
-
9
-
-
20944447546
-
Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial
-
10.1016/S1470-2045(05)70103-0, 15863377
-
Perdona S, Autorino R, De Placido S, D'Armiento M, Gallo A, Damiano R, Pingitore D, Gallo L, De Sio M, Bianco AR, Di Lorenzo G. Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial. Lancet Oncol 2005, 6:295-300. 10.1016/S1470-2045(05)70103-0, 15863377.
-
(2005)
Lancet Oncol
, vol.6
, pp. 295-300
-
-
Perdona, S.1
Autorino, R.2
De Placido, S.3
D'Armiento, M.4
Gallo, A.5
Damiano, R.6
Pingitore, D.7
Gallo, L.8
De Sio, M.9
Bianco, A.R.10
Di Lorenzo, G.11
-
10
-
-
0031451419
-
Tamoxifen for flutamide/finasteride-induced gynecomastia
-
10.1016/S0090-4295(97)00457-3, 9426725
-
Staiman VR, Lowe FC. Tamoxifen for flutamide/finasteride-induced gynecomastia. Urology 1997, 50:929-933. 10.1016/S0090-4295(97)00457-3, 9426725.
-
(1997)
Urology
, vol.50
, pp. 929-933
-
-
Staiman, V.R.1
Lowe, F.C.2
-
11
-
-
0022453573
-
Treatment of gynecomastia with tamoxifen: A double-blind crossover study
-
10.1016/0026-0495(86)90237-4, 3526085
-
Parker LN, Gray DR, Lai MK, Levin ER. Treatment of gynecomastia with tamoxifen: A double-blind crossover study. Metabolism 1986, 35:705-708. 10.1016/0026-0495(86)90237-4, 3526085.
-
(1986)
Metabolism
, vol.35
, pp. 705-708
-
-
Parker, L.N.1
Gray, D.R.2
Lai, M.K.3
Levin, E.R.4
-
12
-
-
34249001119
-
Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study
-
10.1016/j.eururo.2007.01.031, 17270340
-
Fradet Y, Egerdie B, Andersen M, Tammela TLJ, Nachabe M, Armstrong J, Morris T, Navani S. Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study. Eur Urol 2007, 52:106-114. 10.1016/j.eururo.2007.01.031, 17270340.
-
(2007)
Eur Urol
, vol.52
, pp. 106-114
-
-
Fradet, Y.1
Egerdie, B.2
Andersen, M.3
Tammela, T.L.J.4
Nachabe, M.5
Armstrong, J.6
Morris, T.7
Navani, S.8
-
13
-
-
17844367225
-
Prevention and management of bicalutamide-induced gynecomastia and breast pain: randomized endocrinologic and clinical studies with tamoxifen and anastrozole
-
10.1038/sj.pcan.4500782, 15685254
-
Saltzstein D, Sieber P, Morris T, Gallo J. Prevention and management of bicalutamide-induced gynecomastia and breast pain: randomized endocrinologic and clinical studies with tamoxifen and anastrozole. Prostate Cancer Prostatic Dis 2005, 8:75-83. 10.1038/sj.pcan.4500782, 15685254.
-
(2005)
Prostate Cancer Prostatic Dis
, vol.8
, pp. 75-83
-
-
Saltzstein, D.1
Sieber, P.2
Morris, T.3
Gallo, J.4
-
14
-
-
34249042924
-
Bicalutamide-induced gynaecomastia: do we have the answer?
-
10.1016/j.eururo.2007.01.063, 17258386
-
Di Lorenzo G, Autorino R. Bicalutamide-induced gynaecomastia: do we have the answer?. Eur Urol 2007, 52:5-8. 10.1016/j.eururo.2007.01.063, 17258386.
-
(2007)
Eur Urol
, vol.52
, pp. 5-8
-
-
Di Lorenzo, G.1
Autorino, R.2
-
15
-
-
28044452182
-
Management of gynaecomastia in patients with prostate cancer: a systematic review
-
10.1016/S1470-2045(05)70464-2, 16321765
-
Di Lorenzo G, Autorino R, Perdona S, De Placido S. Management of gynaecomastia in patients with prostate cancer: a systematic review. Lancet Oncol 2005, 6:972-979. 10.1016/S1470-2045(05)70464-2, 16321765.
-
(2005)
Lancet Oncol
, vol.6
, pp. 972-979
-
-
Di Lorenzo, G.1
Autorino, R.2
Perdona, S.3
De Placido, S.4
-
16
-
-
33745671627
-
Gynecomastia in patients with prostate cancer: update on treatment options
-
10.1038/sj.pcan.4500859, 16432533
-
Autorino R, Perdona S, D'Armiento M, De Sio M, Damiano R, Cosentino L, Di Lorenzo G. Gynecomastia in patients with prostate cancer: update on treatment options. Prostate Cancer Prostatic Dis 2006, 9:109-114. 10.1038/sj.pcan.4500859, 16432533.
-
(2006)
Prostate Cancer Prostatic Dis
, vol.9
, pp. 109-114
-
-
Autorino, R.1
Perdona, S.2
D'Armiento, M.3
De Sio, M.4
Damiano, R.5
Cosentino, L.6
Di Lorenzo, G.7
-
17
-
-
84867140899
-
Tamoxifen (T) is more effective than anastrozole (A) in preventing gynecomastia induced by bicalutamide (B) monotherapy in prostate cancer (pca) patients (pts)
-
May 31-June 3, Abstract 1608
-
Boccardo F, Rubagotti A, Garofalo L, Di Tonno P, Conti G, Bertaccini A, De Antoni P, Galassi P, Siragusa A, Durand F. Tamoxifen (T) is more effective than anastrozole (A) in preventing gynecomastia induced by bicalutamide (B) monotherapy in prostate cancer (pca) patients (pts). 39th Annual Meeting of the American Society of Clinical Oncology, Chicago 2003, May 31-June 3, Abstract 1608.
-
(2003)
39th Annual Meeting of the American Society of Clinical Oncology, Chicago
-
-
Boccardo, F.1
Rubagotti, A.2
Garofalo, L.3
Di Tonno, P.4
Conti, G.5
Bertaccini, A.6
De Antoni, P.7
Galassi, P.8
Siragusa, A.9
Durand, F.10
-
18
-
-
23244448028
-
Exploratory study of drug plasma levels during bicalutamide 150 mg therapy co-administered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancer
-
10.1007/s00280-005-1016-1, 15838655
-
Boccardo F, Rubagotti A, Conti G, Potenzoni D, Manganelli A, Del Monaco D. Exploratory study of drug plasma levels during bicalutamide 150 mg therapy co-administered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancer. Cancer Chemother Pharmacol 2005, 56:415-420. 10.1007/s00280-005-1016-1, 15838655.
-
(2005)
Cancer Chemother Pharmacol
, vol.56
, pp. 415-420
-
-
Boccardo, F.1
Rubagotti, A.2
Conti, G.3
Potenzoni, D.4
Manganelli, A.5
Del Monaco, D.6
-
19
-
-
84867140600
-
Tamoxifen is safe and effective in preventing gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer and does not alter treatment efficacy
-
Conti G, Cretarola E, Boccardo F, Battaglia M, Di Tonno P, Bertaccini A, De Antoni P, Zattoni F, Galassi P, Durand F. Tamoxifen is safe and effective in preventing gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer and does not alter treatment efficacy. 19th Congress of the European Association of Urology, Vienna 2004,
-
(2004)
19th Congress of the European Association of Urology, Vienna
-
-
Conti, G.1
Cretarola, E.2
Boccardo, F.3
Battaglia, M.4
Di Tonno, P.5
Bertaccini, A.6
De Antoni, P.7
Zattoni, F.8
Galassi, P.9
Durand, F.10
-
20
-
-
34249001119
-
Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer
-
Fradet Y, Egerdie B, Andersen M, Tammela T, Nachabe M, Armstrong J, Morris T, Navani S. Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer. 22nd Annual Congress of the European Association of Urology, Berlin 2007,
-
(2007)
22nd Annual Congress of the European Association of Urology, Berlin
-
-
Fradet, Y.1
Egerdie, B.2
Andersen, M.3
Tammela, T.4
Nachabe, M.5
Armstrong, J.6
Morris, T.7
Navani, S.8
-
21
-
-
27744476741
-
Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: the role of tamoxifen and radiotherapy
-
10.1097/01.ju.0000181824.28382.5c, 16280763
-
Di Lorenzo G, Perdona S, De Placido S, D'Armiento M, Gallo A, Damiano R, Pingitore D, Gallo L, De Sio M, Autorino R. Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: the role of tamoxifen and radiotherapy. J Urol 2005, 174:2197-2203. 10.1097/01.ju.0000181824.28382.5c, 16280763.
-
(2005)
J Urol
, vol.174
, pp. 2197-2203
-
-
Di Lorenzo, G.1
Perdona, S.2
De Placido, S.3
D'Armiento, M.4
Gallo, A.5
Damiano, R.6
Pingitore, D.7
Gallo, L.8
De Sio, M.9
Autorino, R.10
-
22
-
-
0242542209
-
Prophylactic tamoxifen significantly reduces the incidence of bicalutamide-induced gynaecomastia and breast pain
-
Saltzstein D, Cantwell A, Sieber P, Ross JR, Silvay-Mandeau O, Gallo J. Prophylactic tamoxifen significantly reduces the incidence of bicalutamide-induced gynaecomastia and breast pain. BJU Int 2002, 90(Suppl 2):119-122.
-
(2002)
BJU Int
, vol.90
, Issue.SUPPL. 2
, pp. 119-122
-
-
Saltzstein, D.1
Cantwell, A.2
Sieber, P.3
Ross, J.R.4
Silvay-Mandeau, O.5
Gallo, J.6
-
23
-
-
84867139635
-
An open, randomized, multicentre, phase III trial comparing the efficacy of two tamoxifen (T) schedules in preventing gynecomastia (gy) induced by bicalutamide monotherapy (BM) in prostate cancer patients (pca pts)
-
Bedognetti D, Rubagotti A, Conti G, Francesca F, De Cobelli O, Canclini L, Galucci F, Aragona F, Di Tonno P, Boccardo F. An open, randomized, multicentre, phase III trial comparing the efficacy of two tamoxifen (T) schedules in preventing gynecomastia (gy) induced by bicalutamide monotherapy (BM) in prostate cancer patients (pca pts). J Clin Oncol 2009, 27:e16080.
-
(2009)
J Clin Oncol
, vol.27
-
-
Bedognetti, D.1
Rubagotti, A.2
Conti, G.3
Francesca, F.4
De Cobelli, O.5
Canclini, L.6
Galucci, F.7
Aragona, F.8
Di Tonno, P.9
Boccardo, F.10
-
24
-
-
72149085457
-
An open, randomised, multicentre, phase 3 trial comparing the efficacy of two tamoxifen schedules in preventing gynaecomastia induced by bicalutamide monotherapy in prostate cancer patients
-
10.1016/j.eururo.2009.05.019, 19481335
-
Bedognetti D, Rubagotti A, Conti G, Francesca F, De Cobelli O, Canclini L, Gallucci M, Aragona F, Di Tonno P, Cortellini P, Martorana G, Lapini A, Boccardo F. An open, randomised, multicentre, phase 3 trial comparing the efficacy of two tamoxifen schedules in preventing gynaecomastia induced by bicalutamide monotherapy in prostate cancer patients. Eur Urol 2010, 57:238-245. 10.1016/j.eururo.2009.05.019, 19481335.
-
(2010)
Eur Urol
, vol.57
, pp. 238-245
-
-
Bedognetti, D.1
Rubagotti, A.2
Conti, G.3
Francesca, F.4
De Cobelli, O.5
Canclini, L.6
Gallucci, M.7
Aragona, F.8
Di Tonno, P.9
Cortellini, P.10
Martorana, G.11
Lapini, A.12
Boccardo, F.13
-
26
-
-
77955467888
-
Is prophylactic breast radiotherapy necessary in all patients with prostate cancer and gynecomastia and/or breast pain?
-
10.1016/j.juro.2010.03.137, 20620411
-
Ozen H, Akyol F, Toktas G, Eskicorapci S, Unluer E, Kuyumcuoglu U, Abay E, Cureklibatur I, Sengoz M, Yalcin V, Akpinar H, Zorlu F, Sengor F, Karaman I. Is prophylactic breast radiotherapy necessary in all patients with prostate cancer and gynecomastia and/or breast pain?. J Urol 2010, 184:519-524. 10.1016/j.juro.2010.03.137, 20620411.
-
(2010)
J Urol
, vol.184
, pp. 519-524
-
-
Ozen, H.1
Akyol, F.2
Toktas, G.3
Eskicorapci, S.4
Unluer, E.5
Kuyumcuoglu, U.6
Abay, E.7
Cureklibatur, I.8
Sengoz, M.9
Yalcin, V.10
Akpinar, H.11
Zorlu, F.12
Sengor, F.13
Karaman, I.14
-
27
-
-
34249295965
-
Editorial comment on: Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study
-
10.1016/j.eururo.2007.01.032, 17270341
-
Van Poppel H. Editorial comment on: Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study. Eur Urol 2007, 52:115. 10.1016/j.eururo.2007.01.032, 17270341.
-
(2007)
Eur Urol
, vol.52
, pp. 115
-
-
Van Poppel, H.1
-
28
-
-
42049100517
-
Plastic surgery for the treatment of gynaecomastia following hormone therapy in prostate carcinoma
-
10.1007/s00120-007-1567-3, 18210077
-
Ryssel H, Germann G, Kollensperger E, Riedel K. Plastic surgery for the treatment of gynaecomastia following hormone therapy in prostate carcinoma. Urologe A 2008, 47:467-471. 10.1007/s00120-007-1567-3, 18210077.
-
(2008)
Urologe A
, vol.47
, pp. 467-471
-
-
Ryssel, H.1
Germann, G.2
Kollensperger, E.3
Riedel, K.4
-
29
-
-
4544365329
-
Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10 Gy) significantly reduces the incidence of bicalutamide-induced gynecomastia
-
10.1016/j.ijrobp.2004.03.022, 15380582
-
Tyrrell CJ, Payne H, Tammela TL, Bakke A, Lodding P, Goedhals L, Van Erps P, Boon T, Van De Beek C, Andersson SO, Morris T, Carroll K. Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10 Gy) significantly reduces the incidence of bicalutamide-induced gynecomastia. Int J Radiat Oncol Biol Phys 2004, 60:476-483. 10.1016/j.ijrobp.2004.03.022, 15380582.
-
(2004)
Int J Radiat Oncol Biol Phys
, vol.60
, pp. 476-483
-
-
Tyrrell, C.J.1
Payne, H.2
Tammela, T.L.3
Bakke, A.4
Lodding, P.5
Goedhals, L.6
Van Erps, P.7
Boon, T.8
Van De Beek, C.9
Andersson, S.O.10
Morris, T.11
Carroll, K.12
-
30
-
-
0037253622
-
Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3
-
10.1016/S0090-4295(02)02107-6, 12559286
-
Widmark A, Fossa SD, Lundmo P, Damber JE, Vaage S, Damber L, Wiklund F, Klepp O. Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3. Urology 2003, 61:145-151. 10.1016/S0090-4295(02)02107-6, 12559286.
-
(2003)
Urology
, vol.61
, pp. 145-151
-
-
Widmark, A.1
Fossa, S.D.2
Lundmo, P.3
Damber, J.E.4
Vaage, S.5
Damber, L.6
Wiklund, F.7
Klepp, O.8
-
31
-
-
84867140597
-
Prophylactic breast irradiation for prevention of gynecomastia caused by antiandrogen therapy with bicalutamide (casodex 150 mg/d) for prostatic cancer patients
-
Mermershtain W, Lazarev I, Regev E, Ariad S, Lavrenkov K. Prophylactic breast irradiation for prevention of gynecomastia caused by antiandrogen therapy with bicalutamide (casodex 150 mg/d) for prostatic cancer patients. 1st European Multidisciplinary Meeting on Urological Cancer, Barcelona 2007,
-
(2007)
1st European Multidisciplinary Meeting on Urological Cancer, Barcelona
-
-
Mermershtain, W.1
Lazarev, I.2
Regev, E.3
Ariad, S.4
Lavrenkov, K.5
-
32
-
-
0022572502
-
Radiotherapeutic prophylaxis of estrogen-induced gynecomastia: a study of late sequela
-
Fass D, Steinfeld A, Brown J, Tessler A. Radiotherapeutic prophylaxis of estrogen-induced gynecomastia: a study of late sequela. Int J Radiation Oncology Biol Phys 1986, 12:407-408.
-
(1986)
Int J Radiation Oncology Biol Phys
, vol.12
, pp. 407-408
-
-
Fass, D.1
Steinfeld, A.2
Brown, J.3
Tessler, A.4
-
33
-
-
17144409402
-
Efficacy and tolerability of radiotherapy as treatment for bicalutamide-induced gynaecomastia and breast pain in prostate cancer
-
10.1016/j.eururo.2004.12.003, 15826748
-
Van Poppel H, Tyrrell CJ, Haustermans K, Cangh PV, Keuppens F, Colombeau P, Morris T, Garside L. Efficacy and tolerability of radiotherapy as treatment for bicalutamide-induced gynaecomastia and breast pain in prostate cancer. Eur Urol 2005, 47:587-592. 10.1016/j.eururo.2004.12.003, 15826748.
-
(2005)
Eur Urol
, vol.47
, pp. 587-592
-
-
Van Poppel, H.1
Tyrrell, C.J.2
Haustermans, K.3
Cangh, P.V.4
Keuppens, F.5
Colombeau, P.6
Morris, T.7
Garside, L.8
-
34
-
-
0037241913
-
The safety and tolerability of low-dose irradiation for the management of gynaecomastia caused by antiandrogen monotherapy
-
10.1016/S1470-2045(03)00958-6, 12517537
-
Dicker AP. The safety and tolerability of low-dose irradiation for the management of gynaecomastia caused by antiandrogen monotherapy. Lancet Oncol 2003, 4:30-36. 10.1016/S1470-2045(03)00958-6, 12517537.
-
(2003)
Lancet Oncol
, vol.4
, pp. 30-36
-
-
Dicker, A.P.1
-
35
-
-
39749176174
-
Can prophylactic breast irradiation contribute to cardiac toxicity in patients with prostate cancer receiving androgen suppressing drugs?
-
10.1186/1748-717X-3-2, 2249590, 18186924
-
Nieder C, Pawinski A, Andratschke NH, Molls M. Can prophylactic breast irradiation contribute to cardiac toxicity in patients with prostate cancer receiving androgen suppressing drugs?. Radiat Oncol 2008, 3:2. 10.1186/1748-717X-3-2, 2249590, 18186924.
-
(2008)
Radiat Oncol
, vol.3
, pp. 2
-
-
Nieder, C.1
Pawinski, A.2
Andratschke, N.H.3
Molls, M.4
-
36
-
-
0037316419
-
Classification and management of gynecomastia: defining the role of ultrasound-assisted liposuction
-
discussion 924-905, 10.1097/01.PRS.0000042146.40379.25, 12560721
-
Rohrich RJ, Ha RY, Kenkel JM, Adams WP. Classification and management of gynecomastia: defining the role of ultrasound-assisted liposuction. Plast Reconstr Surg 2003, 111:909-923. discussion 924-905, 10.1097/01.PRS.0000042146.40379.25, 12560721.
-
(2003)
Plast Reconstr Surg
, vol.111
, pp. 909-923
-
-
Rohrich, R.J.1
Ha, R.Y.2
Kenkel, J.M.3
Adams, W.P.4
-
37
-
-
33747052557
-
Influence of bicalutamide with or without tamoxifen or anastrozole on insulin-like growth factor 1 and binding proteins in prostate cancer patients
-
Boccardo F, Rubagotti A, Battaglia M, Zattoni F, Bertaccini A, Romagnoli A, Conti G. Influence of bicalutamide with or without tamoxifen or anastrozole on insulin-like growth factor 1 and binding proteins in prostate cancer patients. Int J Biol Markers 2006, 21:123-126.
-
(2006)
Int J Biol Markers
, vol.21
, pp. 123-126
-
-
Boccardo, F.1
Rubagotti, A.2
Battaglia, M.3
Zattoni, F.4
Bertaccini, A.5
Romagnoli, A.6
Conti, G.7
-
38
-
-
84867139238
-
Management of bicalutamide induced gynaecomastia. A randomised study comparing therapy versus prophylaxis with tamoxifen
-
Serretta V, Allegro R, De Grande G, Nicolosi F, Iurato C, Mazza R, Oxenius I, Cosentino V, Vaccarella G, Falsaperla M, Melloni D, Karydi M. Management of bicalutamide induced gynaecomastia. A randomised study comparing therapy versus prophylaxis with tamoxifen. 23rd Annual Congress of the European Association of Urology, Milan 2008,
-
(2008)
23rd Annual Congress of the European Association of Urology, Milan
-
-
Serretta, V.1
Allegro, R.2
De Grande, G.3
Nicolosi, F.4
Iurato, C.5
Mazza, R.6
Oxenius, I.7
Cosentino, V.8
Vaccarella, G.9
Falsaperla, M.10
Melloni, D.11
Karydi, M.12
-
39
-
-
84867139152
-
A randomized trial comparing tamoxifen therapy versus tamoxifen prophylaxis in bicalutamide induced gynecomastia
-
Serretta V, De Grande G, Lapira G, Nicolosi F, Iurato C, De Giacomo E, Ranno S, Cosentino V, Contino G, Falsaperla M, Melloni D, Antonia R, Allegro R. A randomized trial comparing tamoxifen therapy versus tamoxifen prophylaxis in bicalutamide induced gynecomastia. J Urol 2008, 179(4 Supplement):181.
-
(2008)
J Urol
, vol.179
, Issue.4 SUPPL.
, pp. 181
-
-
Serretta, V.1
De Grande, G.2
Lapira, G.3
Nicolosi, F.4
Iurato, C.5
De Giacomo, E.6
Ranno, S.7
Cosentino, V.8
Contino, G.9
Falsaperla, M.10
Melloni, D.11
Antonia, R.12
Allegro, R.13
|